Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Algernon Pharmaceuticals Inc.
C.AGN
Alternate Symbol(s):
AGNPF
Consumer Cyclical
Healthcare
Advertising Agencies
Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N...
-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Company Website
Add To Watchlist
Bullboard (CSE:AGN)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(16)
•••
waves1
X
View Profile
View Bullboard History
Post by
waves1
on Aug 25, 2022 1:55pm
AGN as National Inflation Association's #1 stock
National Inflation Association announced Algernon Pharmaceuticals ($AGN.c $AGNPF) as its #1 favorite biotechnology stock suggestion! NIA highlighted that AGN's largest
...more
(3)
•••
GVX808
X
View Profile
View Bullboard History
Post by
GVX808
on Aug 24, 2022 6:30pm
AGN is our #1 favorite biotech stock in the market today
https://www.inflation.us/content/nias-1-favorite-biotech-stock-suggestion-agn "AGN is our #1 favorite biotech stock in the market today and possibly the #1 biggest
...more
(83)
•••
biggonads
X
View Profile
View Bullboard History
Post by
biggonads
on Aug 24, 2022 12:02pm
AGN's largest shareholder increases ownership position
Algernon’s largest shareholder AlphaNorth has effectively increased their ownership position now up to 13% following the recent announcement of the closing of their private placement generating gross
...more
(83)
•••
biggonads
X
View Profile
View Bullboard History
Post by
biggonads
on Aug 23, 2022 12:41pm
Pivot makes AGN the cheapest psychedelic stock in the market
Algernon is positioned to be one of the cheapest psychedelic stocks in the market with their upcoming development plans for the use of DMT as treatment for ischemic stroke in the brain. This clinical
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 23, 2022 7:15am
New Press Release - Algernon Pharmaceuticals' Largest Shareholder AlphaNorth Asset Management Increases Ownership Position
VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”) is pleased to announce that its largest shareholder, AlphaNorth Asset Management (“AlphaNorth”), has increased its ownership...
read article.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 23, 2022 7:00am
New Press Release - Algernon Pharmaceuticals Announces Closing of Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
read article.
(0)
•••
steveben1954
X
View Profile
View Bullboard History
Comment by
steveben1954
on Aug 23, 2022 6:34am
RE:Promising Progress With Their Research
You must assist me. I'm curious to learn more about the current worth of an O-level in Pakistan. Your assistance is greatly desired.
(21)
•••
StockHawk1
X
View Profile
View Bullboard History
Post by
StockHawk1
on Aug 22, 2022 5:32pm
$AGN closes up 8% with high vol, having $1.4M PP
Algernon Pharmaceuticals Inc. (AGN.c) jumped up 8% today with above-average volume Late last week the pharmaceutical development company shared that it is having a $1.4M non-brokered private
...more
(127)
•••
SkywalkerofLuke
X
View Profile
View Bullboard History
Post by
SkywalkerofLuke
on Aug 22, 2022 4:01pm
AGN to Present at American Cough Conference
AGN.c ANGPF (a clinical stage Canadian pharmaceutical development company) is up 8.1% today. They announced earlier this month that they were invited to present the results from its Phase 2a Study of
...more
(0)
•••
jasonwood174
X
View Profile
View Bullboard History
Comment by
jasonwood174
on Aug 21, 2022 6:31pm
RE:RE:This is in America
As study in canada for pakistani students. It is very good information for us.
(0)
•••
jasonwood174
X
View Profile
View Bullboard History
Comment by
jasonwood174
on Aug 21, 2022 6:30pm
RE:RE:This is in America
I'm overjoyed to be a part of this group. Well, I'm a woodworker and I work with Paragon Education Pakistan.
(43)
•••
Stockydoc
X
View Profile
View Bullboard History
Post by
Stockydoc
on Aug 19, 2022 1:51pm
AGN.c Private placement
AGN.c announced a non-brokered PP yesterday for gross proceeds of $1.4M. The proceeds from the PP will be used to fund research and development programs, general and administrative expenses and for
...more
(16)
•••
waves1
X
View Profile
View Bullboard History
Post by
waves1
on Aug 19, 2022 1:49pm
AGN to be cashed up heading into the 3 Phase I studies in Q4
With three Phase I studies coming up in Q4 2022 and one Phase II study in mid 2023, a private placement is a great move to for AGN to stay cashed up. Specifically, Phase I of
...more
(83)
•••
biggonads
X
View Profile
View Bullboard History
Post by
biggonads
on Aug 18, 2022 1:03pm
AGN announces private placement of up to $1.4M gross proceed
Following recently announced positive results from AGN’s phase 2a clinical trials, and the pursuit of DMT for treatment in ischemic brain stroke, the company has announced a non-brokered private
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Aug 18, 2022 7:00am
New Press Release - Algernon Pharmaceuticals Announces Private Placement
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical...
read article.
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Nanalysis Announces Third Quarter 2024 Conference Call
GameSquare to Report Q3 2024 Financial Results on November 14, 2024
Options Trading for Retiring: Key Strategies in Balancing Retirement Income
Learn About a Mining Portfolio of More Than 250 Projects and Royalties Across North America
Have you held units of a TD mutual fund (other than through a discount broker)? Learn more.